Drug-eluting stents

Antithrombotic Anticoagulants

Cilostazol reduces restenosis of DES in lesions larger than 40 mm.

Original title: Comparison of Dual Versus Triple Antiplatelet Therapy After Drug-Eluting Stent According to Stent Length (from the...

solaci - 7 October, 2013

Coronary disease

Paclitaxel eluting balloon . More effective in restenosis of BMS than DES

Original title: A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal...

solaci - 25 September, 2013

Coronary disease

Everolimus Eluting Stent in multiple vessels with short SYNTAX score

Original title: A Clinical and Angiographic Study of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment...

solaci - 24 September, 2013

Coronary disease

2nd generation drug-eluting stents intended for left main coronary artery

Original title: Zotarolimus- versus Everolimus-Eluting Stents for Unprotected Left Main Coronary Artery Disease. ISAR-LEFT MAIN 2 Study. Reference: Julinda Mehilli...

solaci - 29 August, 2013

Coronary disease

Zotarolimus-eluting stent in-stent restenosis

Original title: Clinical Outcomes of the Resolute Zotarolimus-Eluting Stent in Patients With In-Stent Restenosis Two-Year Results From a...

solaci - 16 August, 2013

Coronary disease

Pharmacological stent intimal coverage with overlap versus no overlap

Original title: Tissue coverage and neointimal hyperplasia in overlap versus nonoverlap segments of drug-eluting stents 9 to 13...

solaci - 5 August, 2013

Acute coronary syndromes

DES versus Bare in primary angioplasty at five years. Initial advantage is reducing

Original: title Long-Term Outcome After Drug-Eluting VersusBare-Metal Stent Implantation in Patients WithST-Segment Elevation Myocardial Infarction. 5 Years Follow-Up...

solaci - 5 July, 2013

Drug-eluting stents

Stent directo, sin utilidad clínica en pacientes electivos (en)

solaci - 16 June, 2013

Cilostazol reduces restenosis of DES in lesions larger than 40 mm.

Paclitaxel eluting balloon . More effective in restenosis of BMS than DES

Everolimus Eluting Stent in multiple vessels with short SYNTAX score

2nd generation drug-eluting stents intended for left main coronary artery

Zotarolimus-eluting stent in-stent restenosis

Pharmacological stent intimal coverage with overlap versus no overlap

DES versus Bare in primary angioplasty at five years. Initial advantage is reducing

Stent directo, sin utilidad clínica en pacientes electivos (en)

Últimas Noticias

Perforation Management in Bifurcations: Bench Testing of Bailout with Covered Stents

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Noticias Institucionales

SOLACI Wishes You Happy Holidays

Condolences on the passing of Cristiam Arancibia

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Accesos